Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06429371 · ClinicalTrials.gov registry record

Biopsychosocial Contributors to Irritability in Individuals With Shoulder Pain

A clinical trial of Shoulder Pain, sponsored by University of Central Florida.

Recruiting
Registry status
60
Enrollment target
1
Study location

NCT06429371 is a study of Shoulder Pain that is actively recruiting participants, run by University of Central Florida. The registered enrollment target is 60 participants, below the 99-participant average among 27 other Shoulder Pain trials with a reported enrollment target (39% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06429371, a study of Shoulder Pain, is actively recruiting participants, sponsored by University of Central Florida.

RECRUITING
Registry status
60 participants
Enrollment target
1
Study location

Study Summary

Irritability was defined by Geoffrey Maitland as the vigor of activity to provoke symptoms, the severity of symptoms, and time for symptoms to subside. Irritability is deeply embedded in the physical therapy clinical decision-making process. However, the mechanisms contributing to irritability are unknown. Therefore, the purpose of this study is to characterize pain sensitivity and pain-related psychological factors by irritability level in individuals with shoulder pain.

Conditions Studied

Interventions

  • OTHER Quantitative Sensory Testing
  • OTHER Pain-Related Psychological Factors

Study Locations (1)

Florida

  • University of Central Florida - Orlando

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2024-05-24
Est. Completion 2026-12-01

Sponsor

University of Central Florida

91 total trials

What the Registry Record Tells You About NCT06429371

The ClinicalTrials.gov registry entry for NCT06429371 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 99-participant average among 27 other Shoulder Pain trials with a reported enrollment target (39% lower). The listed sponsor is University of Central Florida, which has 91 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Shoulder Pain appearing as the primary indexed condition, and to 2 interventions - of which Quantitative Sensory Testing is the first listed.

NCT06429371 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT06429371 about?

NCT06429371 is a clinical study titled "Biopsychosocial Contributors to Irritability in Individuals With Shoulder Pain". Irritability was defined by Geoffrey Maitland as the vigor of activity to provoke symptoms, the severity of symptoms, and time for symptoms to subside. Irritability is deeply embedded in the physical therapy clinical decision-making process. However, the mechanisms contributing to irritability are u...

What is the current status of trial NCT06429371?

This trial is currently recruiting. The enrollment target is 60 participants. The study started on 2024-05-24. Estimated completion is 2026-12-01.

What conditions does trial NCT06429371 study?

This clinical trial studies the following conditions: Shoulder Pain.

What interventions are being tested in trial NCT06429371?

The interventions under investigation include: Quantitative Sensory Testing (OTHER), Pain-Related Psychological Factors (OTHER).

Who is sponsoring clinical trial NCT06429371?

This trial is sponsored by University of Central Florida, which has 91 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06429371 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Shoulder Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.